JAMA Archives
VUMC-led trial shows two investigational drugs are ineffective for treating severe COVID-19
Apr. 11, 2023—A Vanderbilt-led study evaluating two investigational drugs to treat severe COVID-19 demonstrated that neither drug was effective.
Clinical trial compares different therapies for spine pain
Jan. 12, 2023—A Vanderbilt clinical trial to determine whether multidisciplinary biopsychosocial intervention or individualized postural therapy intervention improved disability and reduced health care spending in patients with acute or subacute spine pain.
Study finds administering IV fluids during emergency tracheal intubation does not lower cardiac arrest risk
Jun. 20, 2022—Rapidly administering IV fluids to critically ill adults undergoing emergency tracheal intubation does not significantly decrease chances of hypotension (low blood pressure) and cardiac arrest, a Vanderbilt University Medical Center-led study shows.
Study finds sexual minority communities disproportionately engage in behaviors to reduce medication costs
Jan. 6, 2022—Vanderbilt research finds that individuals from sexual minority populations, including members of the lesbian, gay, bisexual and queer communities, are more likely than heterosexual individuals to engage in behaviors to reduce medication costs.
Study finds sexual minority communities disproportionately engage in behaviors to reduce medication costs
Dec. 29, 2021—People from sexual minority populations, including members of the lesbian, gay, bisexual and queer communities, are more likely than heterosexual people to engage in behaviors to reduce medication costs.
Study finds apixaban (Eliquis) is preferable to rivaroxaban (Xarelto) for stroke prevention, reduced bleeding complications
Dec. 21, 2021— by Jill Clendening There is strong evidence that the medication apixaban (Eliquis) is preferable to rivaroxaban (Xarelto) for stroke prevention in patients with atrial fibrillation (AF), with both reduced rates of severe bleeding complications as well as strokes, according to study published Dec. 21 in JAMA. An estimated 3 million to 6 million persons...
Study finds similar success rates with two devices for breathing tube placement
Dec. 15, 2021—Two devices for placing a breathing tube during critical illness had similar success rates for intubation on the first attempt, according to a study published Dec. 8 in JAMA.
Study shows continuous glucose monitors improve management of type 2 diabetes
Jul. 15, 2021—For patients with type 2 diabetes treated with basal or long-acting insulin, the use of continuous glucose monitors (CGMs) can result in significantly lower hemoglobin A1C (a blood test that reflects average blood glucose levels over three months), and better management of the disease according to a study recently published in the journal JAMA.
Strength training for osteoarthritis
Mar. 18, 2021—High-intensity strength training is not more effective than low-intensity training or educational efforts for reducing knee pain in patients with osteoarthritis.
Study shows drastic increases in opioid-affected births
Jan. 12, 2021—The rate of mothers who had an opioid-related diagnosis when delivering their baby increased by 131% from 2010-2017, as the incidence of babies diagnosed with drug withdrawal, known as neonatal abstinence syndrome (NAS), increased by 82% nationally during that same time period.
JAMA Health Forum to become full-fledged journal in 2021
Dec. 3, 2020—Just a year after its founding as an online channel of information, the Journal of the American Medical Association’s (JAMA’s) Health Forum will become a full-fledged journal in January 2021.
Hydroxychloroquine does not help patients hospitalized with COVID-19: Study
Nov. 9, 2020—Findings from a national study published Nov. 9 in the Journal of the American Medical Association (JAMA) “do not support” the use of hydroxychloroquine for the treatment of adult patients hospitalized with COVID-19, the report concludes.
